436 related articles for article (PubMed ID: 24861084)
21. SMPDL3b modulates radiation-induced DNA damage response in renal podocytes.
Francis M; Ahmad A; Bodgi L; Azzam P; Youssef T; Abou Daher A; Eid AA; Fornoni A; Pollack A; Marples B; Zeidan YH
FASEB J; 2022 Oct; 36(10):e22545. PubMed ID: 36094323
[TBL] [Abstract][Full Text] [Related]
22. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
23. APOL1-G0 protects podocytes in a mouse model of HIV-associated nephropathy.
Bruggeman LA; Wu Z; Luo L; Madhavan S; Drawz PE; Thomas DB; Barisoni L; O'Toole JF; Sedor JR
PLoS One; 2019; 14(10):e0224408. PubMed ID: 31661509
[TBL] [Abstract][Full Text] [Related]
24. Permeability factors in focal and segmental glomerulosclerosis.
Reiser J; Nast CC; Alachkar N
Adv Chronic Kidney Dis; 2014 Sep; 21(5):417-21. PubMed ID: 25168830
[TBL] [Abstract][Full Text] [Related]
25. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
[TBL] [Abstract][Full Text] [Related]
26. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
[TBL] [Abstract][Full Text] [Related]
27. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.
Ren G; Tardi NJ; Matsuda F; Koh KH; Ruiz P; Wei C; Altintas MM; Ploegh H; Reiser J
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F471-F482. PubMed ID: 29167172
[TBL] [Abstract][Full Text] [Related]
28. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
Lee HS
Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
[TBL] [Abstract][Full Text] [Related]
30. Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes.
Yang Q; Hu J; Yang Y; Chen Z; Feng J; Zhu Z; Wang H; Yang D; Liang W; Ding G
Theranostics; 2020; 10(16):7465-7479. PubMed ID: 32642006
[TBL] [Abstract][Full Text] [Related]
31. APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.
Bruggeman LA; Wu Z; Luo L; Madhavan SM; Konieczkowski M; Drawz PE; Thomas DB; Barisoni L; Sedor JR; O'Toole JF
J Am Soc Nephrol; 2016 Dec; 27(12):3600-3610. PubMed ID: 27026370
[TBL] [Abstract][Full Text] [Related]
32. From man to fish: What can Zebrafish tell us about ApoL1 nephropathy?
Olabisi O; Al-Romaih K; Henderson J; Tomar R; Drummond I; MacRae C; Pollak M
Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):114-118. PubMed ID: 27509583
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y
BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146
[TBL] [Abstract][Full Text] [Related]
34. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II induces cholesterol accumulation and injury in podocytes.
Yang Y; Yang Q; Yang J; Ma Y; Ding G
Sci Rep; 2017 Sep; 7(1):10672. PubMed ID: 28878222
[TBL] [Abstract][Full Text] [Related]
36. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
37. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
Raij L; Tian R; Wong JS; He JC; Campbell KN
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
[TBL] [Abstract][Full Text] [Related]
38. Familial FSGS.
Pollak MR
Adv Chronic Kidney Dis; 2014 Sep; 21(5):422-5. PubMed ID: 25168831
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
40. Editing of APOL1 mRNA reduces APOL1 expression and activation of innate immunity.
Karttunen H; Ross MJ
Kidney Int; 2023 Aug; 104(2):230-233. PubMed ID: 37224919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
